Dries De Wolf/LinkedIn
Aug 20, 2026, 01:19
Dries De Wolf: Innovative Gene Therapy for Hemophilia B
Dries De Wolf, Postdoctoral Researcher at the Institute of Regenerative Medicine (IREM), shared a post on LinkedIn:
“The Vrije Universiteit Brussel posted a press release article on my recent research paper, in which we designed and validated a novel gene therapy approach for the bleeding disorder Hemophilia B.
You can read the press release in the link below.”
Stay updated with Hemostasis Today.
-
Aug 20, 2026, 01:23Jessica Erley: Understanding Patient Experience Beyond the Clinical Encounter
-
Aug 19, 2026, 19:09Gregory Lip: PFO Closure in Younger Patients With Cryptogenic Stroke
-
Aug 19, 2026, 18:51Filippo Crea: AF and Alzheimer’s Disease – Does the Anticoagulant Choice Matter for the Brain?
-
Aug 19, 2026, 18:42Alan Nurden: How Procoagulant Platelets Relate to Microparticle Release?
-
Aug 19, 2026, 18:25Ivan Centeno Sáenz: FeNO and Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease
-
Aug 19, 2026, 18:10Ahmad Hazri Mohamed Aris: Strengthening Hemophilia Care and Access to Treatment in Fiji
-
Aug 19, 2026, 17:58Paulomi Ghosh: Delighted to Deliver a Talk on Hemostasis and Hemorrhage Control
-
Aug 19, 2026, 17:34Ryan O’Keefe: Clopidogrel Non-Responders and the Risk of Stent Thrombosis
-
Aug 19, 2026, 17:10Mavis Agnes Kisakye: Raising Awareness and Supporting Patients With Bleeding Disorders